HudaSalmanMD
Hematology • Indianapolis, INHematologic Oncology
Associate Professor, Internal Medicine, Stony Brook University School of Medicine
Dr. Salman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Brown center Indiana University
Indianapolis, IN 46202
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 1999 - 2002
Lincoln Medical and Mental Health CenterResidency, Internal Medicine, 1996 - 1999
University of Jordan Faculty of MedicineClass of 1991
Certifications & Licensure
IN State Medical License 2021 - 2025
NY State Medical License 2015 - 2022
GA State Medical License 2013 - 2016
VA State Medical License 2011 - 2014
OH State Medical License 2009 - 2012
MO State Medical License 2006 - 2010
TN State Medical License 2005 - 2007
American Board of Internal Medicine Hematology
Clinical Trials
- CD4CAR for CD4+ Leukemia and Lymphoma Start of enrollment: 2020 Jul 09
Roles: Study Chair, Contact, Sponsor-Investigator, Principal Investigator
- Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second Line Treatment for Chronic Myelomonocytic Leukemia, CMML. Start of enrollment: 2024 Feb 21
Roles: Principal Investigator, Sponsor-Investigator, Contact
- Chimeric Antigen Receptor T Cell Redirected to Target CD4 Positive Relapsed Refractory Acute Myeloid Leukemia (AML ) As a Bridge to Allogeneic Stem Cell Transplant Start of enrollment: 2024 Mar 19
Roles: Principal Investigator, Sponsor-Investigator, Contact
Publications & Presentations
PubMed
- Ancestral Differences in Anticancer Treatment Efficacy and Their Underlying Genomic and Molecular Alterations.Mei Luo, Jingwen Yang, Alejandro A Schäffer, Chengxuan Chen, Yuan Liu
Cancer Discovery. 2025-03-03 - Engineering resilient CAR T cells for immunosuppressive environment.Malak Khalifeh, Huda Salman
Molecular Therapy. 2025-01-25 - 2 citationsNCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024.John A Thompson, Bryan J Schneider, Julie Brahmer, Mohammad Abu Zaid, Amaka Achufusi
Journal of the National Comprehensive Cancer Network. 2024-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
